Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial

Coles, Alasdair J, Dr ; Twyman, Cary L, MD ; Arnold, Douglas L, Prof ; Cohen, Jeffrey A, Prof ; Confavreux, Christian, Prof ; Fox, Edward J, MD ; Hartung, Hans-Peter, Prof ; Havrdova, Eva, Prof ; Selmaj, Krzysztof W, Prof ; Weiner, Howard L, Prof ; Miller, Tamara, MD ; Fisher, Elizabeth, PhD ; Sandbrink, Rupert, MD ; Lake, Stephen L, ScD ; Margolin, David H, MD ; Oyuela, Pedro, MD ; Panzara, Michael A, MD ; Compston, D Alastair S, Prof

The Lancet (British edition), 2012-11, Vol.380 (9856), p.1829-1839 [Periódico revisado por pares]

Kidlington: Elsevier Ltd

Texto completo disponível